Stocktoria
IRONWOOD PHARMACEUTICALS INC IRWD
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2010-02-03
IRONWOOD PHARMACEUTICALS INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $296.2M | $351.4M | $442.7M | $410.6M | $413.8M |
| R&D expense | $95.1M | $111.4M | $116.1M | $44.3M | $70.4M |
| SG&A expense | $82.3M | $144.3M | $158.3M | $116.0M | $111.1M |
| Operating income | $98.5M | $93.1M | -$945.4M | $250.3M | $232.3M |
| Interest expense | — | — | $21.6M | $7.6M | $31.1M |
| Income tax | $46.0M | $64.3M | $83.5M | $77.4M | -$327.8M |
| Net income | $24.0M | $880,000 | -$1.0B | $175.1M | $528.4M |
| EPS (diluted) | $0.15 | $0.01 | $-6.45 | $0.96 | $3.21 |
| Operating cash flow | $127.0M | $103.5M | $183.4M | $273.8M | $261.9M |
| Free cash flow | $127.0M | $103.4M | $183.2M | $273.6M | $261.6M |
| Cash & equivalents | $215.5M | $88.6M | $92.2M | $656.2M | $620.1M |
| Total assets | $396.9M | $350.9M | $471.1M | $1.1B | $1.1B |
| Shareholders' equity | -$261.8M | -$301.3M | -$346.3M | $652.4M | $605.9M |
Source: SEC EDGAR filings · CIK 0001446847 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.